Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): Safety and efficacy

American Journal of Transplantation

Volumn 3, Issue 3, 2003, Pages 312-317

  Maluf, D ^a   Fisher, Robert A ^a   Maroney, T ^a   Cotterell, A ^a   Fulcher, A ^a   Tisnado, J ^a   Contos, M ^a   Luketic, V ^a   Stravitz, R ^a   Shiffman, M ^a   Sterling, R ^a   Posner, M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Non resective ablation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSURGERY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; RADIOFREQUENCY; SAFETY; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FIBROSIS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037355157     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00041.x     Document Type: Article

References (33)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med 1988; 108: 309-401.
2. Shimada M, Yamashita Y, Hamatsu T et al. Surgical indication for advanced hepatocellular carcinoma. Hepatogastroenterology 2000; 47; 1095-1099.
3. Klintmalm GB. Liver transplantation for hepatocellular carcinoma. A registry report on the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479-490.
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
5. Figueras J, Jaurrieta E, Valls C et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. Am Coll Surg 2000; 190: 580-587.
6. Shimada M, Gion T, Harnatsu T et al. Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 401-406.
7. Iwatsuki S, Dvorchik I, Marsh JW et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: 389-394.
8. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis of HCC. A cost effectiveness analysis. Gut 2001; 48: 251-259.
9. Takenaka K, Kawahara N, Yamamoto K et al. Results of 280 liver resection for hepatocellular carcinoma. Arch Surg 1996; 131: 71-76.
10. Bismuth H, Morino M, Sherlock D et al. Primary treatment for hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387-394.
11. Schwartz M, Sung M, Mor E et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995; 180: 596-603.
12. Ismail T, Angrisani L, Gunson BK et al. Primary hepatic malignancy: the role of liver transplantation. Br Ann Surg 1990; 77: 983-987.
13. Pichlmayr R, Weimann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: clinical result and future aspects. Cancer Chemother Pharmacol 1992; 31 (Suppl): 157-161.
14. Iwatsuki S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993; 9: 337-340.
15. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
16. Mor E, Kaspa R, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643-653.
17. Matsunami H, Shimizu Y, Lynch S, Balderson G, Ando Y, Strong R. Liver transplantation as a therapeutic option for hepatocellular carcinoma. Oncology 2002; 62 (Suppl. 1): 82-86.
18. Bruix J, Llovet J. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524.
19. Fisher R, Maroney T, Fulcher A et al. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation. Clin Transplantation 2002; 16 (Suppl. 7): 52-58.
20. Marano I, DellaNoce M, Stagni V et al. Magnetic resonance in surgical planning in hepatocarcinomas. Radiol Med 1995; 89: 94-99.
21. Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM. Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 1998; 207: 21-32.
22. American Liver Tumor Study Group. A Randomized Prospective Multi-Institutional Trial of Orthotopic Liver Transplantation or Partial Hepatic Resection With or Without Adjuvant Chemotherapy for Hepatocellular Carcinoma. Investigators Booklet and Protocol. 1998. Unived Network of Organ Sharing; Policy 3.6.4.4. 1998.
23. Fisher RA, Ham JM, Marcos A, Shiffman ML et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998; 66: 1616-1621.
24. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-years experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002; 131 (Suppl): 153-157.
25. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 217: 114-117.
26. Curley S, Izzo F, Ellis L, Vauthey N, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391.
27. Yamada R, Sato M, Kawabata M et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401.
28. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: result of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-1583.
29. Chung J, Park J, Han J et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198: 33-40.
30. Cheng S J, Pratt DS, Freeman RB, Jr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for nonresectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001; 72: 861-868.
31. Archor JP, Araya V, Baron RL, Marsh HW, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transplant Surg 1998; 4: 477-482.
32. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and liver transplantation in 198 patients. World J Surg 1991; 15: 270-285.
33. Selby R, Zakijah K, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995; 19: 53-58.